Published in Proc Natl Acad Sci U S A on December 13, 2010
Sex steroid actions in male bone. Endocr Rev (2014) 1.26
Control of bone resorption by semaphorin 4D is dependent on ovarian function. PLoS One (2011) 1.01
FSH and TSH in the regulation of bone mass: the pituitary/immune/bone axis. Clin Dev Immunol (2013) 0.92
Blocking FSH action attenuates osteoclastogenesis. Biochem Biophys Res Commun (2012) 0.91
Follicle-stimulating hormone is independently associated with lean mass but not BMD in younger postmenopausal women. Bone (2011) 0.90
Androgens and estrogens in skeletal sexual dimorphism. Asian J Androl (2014) 0.85
Thiazolidinediones on PPARγ: The Roles in Bone Remodeling. PPAR Res (2011) 0.85
Pharmacogenetics of follicle-stimulating hormone action. Curr Opin Endocrinol Diabetes Obes (2012) 0.85
Follicle stimulating hormone receptor in mesenchymal stem cells integrates effects of glycoprotein reproductive hormones. Ann N Y Acad Sci (2014) 0.82
Dextromethorphan inhibits osteoclast differentiation by suppressing RANKL-induced nuclear factor-κB activation. Osteoporos Int (2013) 0.79
Decreased bone mineral density in rats rendered follicle-deplete by an ovotoxic chemical correlates with changes in follicle-stimulating hormone and inhibin A. Calcif Tissue Int (2012) 0.76
Animal models for aberrations of gonadotropin action. Rev Endocr Metab Disord (2011) 0.76
Estrogens, the be-all and end-all of male hypogonadal bone loss? Osteoporos Int (2014) 0.75
FSH suppression does not affect bone turnover in eugonadal men. J Clin Endocrinol Metab (2014) 0.75
Extragonadal FSH receptor: is it real? Biol Reprod (2014) 0.75
Live imaging of follicle stimulating hormone receptors in gonads and bones using near infrared II fluorophore. Chem Sci (2017) 0.75
FSH directly regulates bone mass. Cell (2006) 4.64
The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev (1997) 2.44
Effects of suppression of follicle-stimulating hormone secretion on bone resorption markers in postmenopausal women. J Clin Endocrinol Metab (2010) 2.33
Altered ovarian function affects skeletal homeostasis independent of the action of follicle-stimulating hormone. Endocrinology (2007) 1.94
Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc Natl Acad Sci U S A (2006) 1.64
Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures. Endocrinology (2002) 1.61
Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest (1975) 1.60
Trabecular bone pattern factor--a new parameter for simple quantification of bone microarchitecture. Bone (1992) 1.53
Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab (1996) 1.52
Induction of spermatogenesis by androgens in gonadotropin-deficient (hpg) mice. Endocrinology (1995) 1.47
Inhibin A is an endocrine stimulator of bone mass and strength. Endocrinology (2006) 1.41
Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling. J Biol Chem (2007) 1.37
The effect of age on the cyclical patterns of plasma LH, FSH, oestradiol and progesterone in women with regular menstrual cycles. Hum Reprod (1988) 1.21
Progressive changes in LH and FSH and LH: FSH ratio in women throughout reproductive life. Maturitas (1988) 1.18
FSH-receptor isoforms and FSH-dependent gene transcription in human monocytes and osteoclasts. Biochem Biophys Res Commun (2010) 1.12
Development and validation of a sensitive liquid chromatography-tandem mass spectrometry assay to simultaneously measure androgens and estrogens in serum without derivatization. Clin Chim Acta (2009) 1.10
A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles. Menopause (2008) 1.10
A novel osteoblast-derived C-type lectin that inhibits osteoclast formation. J Biol Chem (2001) 1.01
Longitudinal in vivo analysis of the region-specific efficacy of parathyroid hormone in a rat cortical defect model. Endocrinology (2008) 1.01
Measurement of sex steroids in murine blood and reproductive tissues by liquid chromatography-tandem mass spectrometry. J Steroid Biochem Mol Biol (2010) 1.00
A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas (2009) 0.99
Sex hormones and their receptors in bone homeostasis: insights from genetically modified mouse models. Osteoporos Int (2009) 0.98
Bone loss goes beyond estrogen. Nat Med (2006) 0.97
Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin A may contribute in part to the rise in follicular phase follicle-stimulating hormone of aging cycling women. J Clin Endocrinol Metab (1998) 0.97
Interrelationships between ovarian and pituitary hormones in ovulatory menstrual cycles across reproductive age. J Clin Endocrinol Metab (2008) 0.96
Proresorptive actions of FSH and bone loss. Ann N Y Acad Sci (2007) 0.92
FSH versus estrogen: who's guilty of breaking bones? Cell Metab (2006) 0.89
A novel transgenic model to characterize the specific effects of follicle-stimulating hormone on gonadal physiology in the absence of luteinizing hormone actions. Endocrinology (2001) 0.89
Rising follicle-stimulating hormone levels with age accelerate female reproductive failure. Endocrinology (2007) 0.88
Gonadotropin control of inhibin secretion and the relationship to follicle type and number in the hpg mouse. Biol Reprod (2005) 0.88
Follicle-stimulating hormone increases primordial follicle reserve in mature female hypogonadal mice. J Endocrinol (2006) 0.87
Complete Sertoli cell proliferation induced by follicle-stimulating hormone (FSH) independently of luteinizing hormone activity: evidence from genetic models of isolated FSH action. Endocrinology (2004) 0.87
Regulation of luteinizing hormone-receptor and follicle-stimulating hormone-receptor messenger ribonucleic acid levels during development in the neonatal mouse ovary. Biol Reprod (1997) 0.86
Sex steroids, not FSH, influence bone mass. Cell (2006) 0.86
Inhibin and the regulation of bone mass. Curr Osteoporos Rep (2008) 0.85
Validation of an ultrasensitive and specific immunofluorometric assay for mouse follicle-stimulating hormone. Biol Reprod (2004) 0.85
FSH and bone--important physiology or not? Trends Mol Med (2006) 0.81
Transgenic models for exploring gonadotropin biology in the male. Endocrine (2005) 0.77
Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med (2006) 4.10
Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria. Infect Immun (2005) 3.72
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol (2012) 3.57
A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. J Bone Miner Res (2004) 3.17
Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust (2012) 3.14
In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while estradiol levels do not predict mortality. J Clin Endocrinol Metab (2013) 3.11
The burden of influenza-associated critical illness hospitalizations. Crit Care Med (2014) 2.84
Androgens and cardiovascular disease. Endocr Rev (2003) 2.71
Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost (2003) 2.62
Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism. J Clin Invest (2012) 2.38
Genetic compatibility and virulence of reassortants derived from contemporary avian H5N1 and human H3N2 influenza A viruses. PLoS Pathog (2008) 2.38
Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial. Ann Intern Med (2010) 2.29
Sex steroids and all-cause and cause-specific mortality in men. Arch Intern Med (2007) 2.27
Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men. Lancet (2005) 2.25
Monitoring influenza activity in the United States: a comparison of traditional surveillance systems with Google Flu Trends. PLoS One (2011) 2.21
Ulinastatin is a novel candidate drug for sepsis and secondary acute lung injury, evidence from an optimized CLP rat model. Int Immunopharmacol (2013) 2.06
Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM). Oncogene (2005) 2.06
An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. Nat Immunol (2010) 2.03
Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity. Infect Immun (2006) 2.02
Loss of muscle strength, mass (sarcopenia), and quality (specific force) and its relationship with functional limitation and physical disability: the Concord Health and Ageing in Men Project. J Am Geriatr Soc (2010) 1.97
Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. J Clin Endocrinol Metab (2002) 1.96
No more excuses: fracture liaison services work and are cost-effective. Med J Aust (2011) 1.93
Incidence of venous thromboembolism and the impact on survival in breast cancer patients. J Clin Oncol (2007) 1.92
Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults. Arch Intern Med (2005) 1.90
Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol (2006) 1.89
Serum osteoprotegerin levels in healthy controls and cancer patients. Clin Cancer Res (2002) 1.88
Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci U S A (2003) 1.87
Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ Res (2012) 1.85
Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg (2007) 1.83
Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med (Maywood) (2004) 1.82
Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malaria. PLoS One (2008) 1.81
Pain, frailty and comorbidity on older men: the CHAMP study. Pain (2008) 1.79
The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy. Endocrinology (2005) 1.78
A sex-specific role for androgens in angiogenesis. J Exp Med (2010) 1.78
Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost (2005) 1.77
Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis. Cancer Res (2004) 1.75
Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum (2002) 1.72
Mice that exclusively express TLR4 on endothelial cells can efficiently clear a lethal systemic Gram-negative bacterial infection. J Clin Invest (2009) 1.70
The incidence and case-fatality rates of acute biliary, alcoholic, and idiopathic pancreatitis in California, 1994-2001. Pancreas (2006) 1.70
Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: implications for vaccine design. Proc Natl Acad Sci U S A (2008) 1.69
Influenza-associated mortality in temperate and subtropical Chinese cities, 2003-2008. Bull World Health Organ (2012) 1.69
The coding of uniform colour figures in monkey visual cortex. J Physiol (2003) 1.67
Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain. J Clin Invest (2010) 1.67
A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases. Cancer (2003) 1.65
Atypical femoral fractures and bisphosphonate use. N Engl J Med (2010) 1.64
Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J Neuroimmunol (2002) 1.62
Management of parapharyngeal-space tumors. J Oral Maxillofac Surg (2009) 1.61
Water use and the thermoregulatory behaviour of kangaroos in arid regions: insights into the colonisation of arid rangelands in Australia by the Eastern Grey Kangaroo (Macropus giganteus). J Comp Physiol B (2005) 1.60
How fast does the Grim Reaper walk? Receiver operating characteristics curve analysis in healthy men aged 70 and over. BMJ (2011) 1.59
Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial. Ann Intern Med (2006) 1.59
Phase 1 study of two merozoite surface protein 1 (MSP1(42)) vaccines for Plasmodium falciparum malaria. PLoS Clin Trials (2007) 1.58
Drug Burden Index and physical function in older Australian men. Br J Clin Pharmacol (2009) 1.58
Men in Australia Telephone Survey (MATeS): predictors of men's help-seeking behaviour for reproductive health disorders. Med J Aust (2006) 1.55
Hypovitaminosis D and parathyroid hormone response in the elderly: effects on bone turnover and mortality. Clin Endocrinol (Oxf) (2007) 1.55
Within-subject variability and analytic imprecision of insulinlike growth factor axis and collagen markers: implications for clinical diagnosis and doping tests. Clin Chem (2008) 1.55
Molecular determinants of Ca(2+)/calmodulin-dependent regulation of Ca(v)2.1 channels. Proc Natl Acad Sci U S A (2003) 1.52
Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice. J Hepatol (2012) 1.51
miR-145 inhibits breast cancer cell growth through RTKN. Int J Oncol (2009) 1.49
Death due to recurrent thromboembolism among younger healthier individuals hospitalized for idiopathic pulmonary embolism. Thromb Haemost (2008) 1.47
Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assay. Clin Vaccine Immunol (2009) 1.46
Lower plasma testosterone or dihydrotestosterone, but not estradiol, is associated with symptoms of intermittent claudication in older men. Clin Endocrinol (Oxf) (2013) 1.45
Model structure and control of bone remodeling: a theoretical study. Bone (2008) 1.44
Venous thromboembolism in ovarian cancer. Gynecol Oncol (2007) 1.42
Swimming and other sporting activities and the rate of falls in older men: longitudinal findings from the Concord Health and Ageing in Men Project. Am J Epidemiol (2014) 1.40
Atypical femur fractures: a complication of prolonged bisphosphonate therapy? Med J Aust (2010) 1.40
MicroRNA hsa-miR-138 inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells through adenovirus EID-1. Stem Cells Dev (2010) 1.39
Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. Am J Pathol (2002) 1.38
Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling. J Biol Chem (2007) 1.37
Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression. Stem Cells Dev (2012) 1.34
Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccination. J Immunol (2008) 1.34
Enhancement of functional antibody responses to AMA1-C1/Alhydrogel, a Plasmodium falciparum malaria vaccine, with CpG oligodeoxynucleotide. Vaccine (2006) 1.33
Rationale for the role of osteoclast-like cells in arterial calcification. FASEB J (2002) 1.32
Point mutation of the proteasome beta5 subunit gene is an important mechanism of bortezomib resistance in bortezomib-selected variants of Jurkat T cell lymphoblastic lymphoma/leukemia line. J Pharmacol Exp Ther (2008) 1.30
Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet (2006) 1.30
Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. Arch Intern Med (2008) 1.29
Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidates. Vaccine (2007) 1.28
The immediate economic impact of maternal deaths on rural Chinese households. PLoS One (2012) 1.28
Integral role of GDF-9 and BMP-15 in ovarian function. Mol Reprod Dev (2011) 1.26
Contraceptive efficacy of a depot progestin and androgen combination in men. J Clin Endocrinol Metab (2003) 1.26
Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study. Clin Endocrinol (Oxf) (2012) 1.24
Localization of pigment epithelium-derived factor in growing mouse bone. Calcif Tissue Int (2004) 1.23
Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res (2004) 1.22
Hypophosphatemic osteomalacia after low-dose adefovir dipivoxil therapy for hepatitis B. J Clin Endocrinol Metab (2010) 1.22
Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis. Cancer Res (2010) 1.22
Interferon-gamma expression by intraepithelial lymphocytes results in a loss of epithelial barrier function in a mouse model of total parenteral nutrition. Ann Surg (2002) 1.21